Paper76166
Prevention by bedtime cimetidine of duodenal-ulcer relapse.
Blackwood WS and 2 others. Lancet, 1978. Cited by 91 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Prevention by bedtime cimetidine of duodenal-ulcer relapse. Papers, record 76166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/76166
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Case Reports, Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cimetidine | Major topic |
| Duodenal Ulcer | Major topic |
| Guanidines | Major topic |
| Adult | |
| Child | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Drug Evaluation | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| In Vitro Techniques | |
| Infant | |
| Male | |
| Middle Aged | |
| Placebos | |
| Recurrence | |
| Time Factors |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,410,042 | Cimetidine and duodenal ulcer: a study of initial and low dosage maintenance treatment in Ireland. | Ir J Med Sci | 1980 | https://conductscience.org/library/papers/7410042 | PubMed |
| 7,259,925 | Cimetidine-a clinical and pharmacokinetic study. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7259925 | PubMed |
| 7,220,403 | Effect of treatment with cimetidine for one year on gastrin cell and parietal cell function and sensitivity to cimetidine in patients with duodenal or gastric ulcers. | Postgrad Med J | 1980 | https://conductscience.org/library/papers/7220403 | PubMed |
| 7,205,728 | Problems in the medical treatment of peptic ulcers. | J R Coll Physicians Lond | 1980 | https://conductscience.org/library/papers/7205728 | PubMed |
| 7,040,178 | Bedtime cimetidine maintenance treatment: optimum dose and effect on subsequent natural history of duodenal ulcer. | Gut | 1982 | https://conductscience.org/library/papers/7040178 | PubMed |
| 7,000,474 | Cimetidine vs placebo in duodenal ulcer therapy. Six-week controlled double-blind investigation without any antacid therapy. | Dig Dis Sci | 1980 | https://conductscience.org/library/papers/7000474 | PubMed |
| 6,986,242 | Relapse rate of duodenal ulcer after cessation of long-term cimetidine treatment: a double-blind controlled study. | Dig Dis Sci | 1980 | https://conductscience.org/library/papers/6986242 | PubMed |
| 6,786,895 | Effect of fifteen months of double-blind treatment with cimetidine and placebo on peptic ulcer recurrence. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/6786895 | PubMed |
| 6,311,692 | Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer. | Gut | 1983 | https://conductscience.org/library/papers/6311692 | PubMed |
| 6,141,898 | Effect of a new potent H2-receptor antagonist on meal-stimulated gastric acid secretion and serum gastrin concentration in duodenal ulcer patients. | Dig Dis Sci | 1984 | https://conductscience.org/library/papers/6141898 | PubMed |
| 3,792,425 | Effect of 11R, 16, 16-trimethyl prostaglandin E2 on meal-stimulated gastric acid secretion in duodenal ulcer subjects. | Eur J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3792425 | PubMed |
| 3,080,282 | Effect of misoprostol, an antiulcer prostaglandin, on serum gastrin in patients with duodenal ulcer. | Dig Dis Sci | 1986 | https://conductscience.org/library/papers/3080282 | PubMed |
| 678,819 | Maintenance treatment of duodenal ulcer with cimetidine. | Br Med J | 1978 | https://conductscience.org/library/papers/678819 | PubMed |
| 532,144 | Medical staff conference: cimetidine. | West J Med | 1979 | https://conductscience.org/library/papers/532144 | PubMed |
| 482,183 | Cimetidine in the prevention of gastric ulcer relapse. | Postgrad Med J | 1979 | https://conductscience.org/library/papers/482183 | PubMed |
| 421,004 | Cimetidine and duodenal ulcer. | Br Med J | 1979 | https://conductscience.org/library/papers/421004 | PubMed |
| 382,159 | Review of general surgery 1978. | Postgrad Med J | 1979 | https://conductscience.org/library/papers/382159 | PubMed |
| 381,127 | Controlled trial of maintenance cimetidine treatment in healed duodenal ulcer: short and long-term effects. | Gut | 1979 | https://conductscience.org/library/papers/381127 | PubMed |
| 378,626 | Long-term cimetidine in duodenal ulcer disease. | Dig Dis Sci | 1979 | https://conductscience.org/library/papers/378626 | PubMed |
| 342,231 | Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease. | Drugs | 1978 | https://conductscience.org/library/papers/342231 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/76166
GET https://conductscience.org/api/papers/v1/76166/cited_by?page=2